J Appl Biomed 14:229-234, 2016 | DOI: 10.1016/j.jab.2016.03.002

Antitumoral activity of novel 1,4-naphthoquinone derivative involves L-type calcium channel activation in human colorectal cancer cell line

Juan Carlos Ramos Gonçalvesa,b,*, Tangbadioa Herve Coulidiatia, André Luís Monteiroa, Laís Campos Teixeira de Carvalho-Gonçalvesa, Wagner de Oliveira Valençac, Ronaldo Nascimento de Oliveirac, Celso de Amorim Câmarac, Demetrius Antônio Machado de Araújoa
a Department of Biotechnology, Federal University of Paraiba, João Pessoa, Brazil
b Department of Biochemistry and Pharmacology, Federal University of Piauí, Teresina, Brazil
c Department of Molecular Sciences, Rural Federal University of Pernambuco, Recife, Brazil

Colorectal cancer (CRC) is an important public health problem estimated as the third most commonly diagnosed cancer worldwide. Naphthoquinones are compounds present in different families of plants and interesting for medicinal chemistry due to their activities as potent inhibitors of human cancer growth. In this way, our study aimed to evaluate the cytotoxicity and selectiveness of four 2,3-triazole-1,4-naphthoquinone derivatives (N1-N4) towards the CRC cell line HT-29 and normal human cells. MTT assay showed that N1, N2, N3 and N4 elicited distinct cytotoxic potency, exhibiting EC50 values of 40.6 ± 1.0, 100.1 ± 1.0, 241.9 ± 1.2 and 101.9 ± 1.1, respectively. Later, flow cytometry in HT-29 cells loaded with propidium iodide (5 μM), indicated the ability of N4 (0.5-50 μM) to induce cell membrane damage. Additionally, calcium imaging experiments were conducted in HT-29 cells loaded with 5 μM Fluo-3/AM to assess intracellular Ca2+ (iCa2+). Our data demonstrated that N4 induces a fast and strong increase of iCa2+ in HT-29 cells, mediated by voltage-gated L-type Ca2+ channels activation. In conclusion, our study reported on the cytotoxicity and selectiveness of 1,2,3-triazol substituted 1,4-naphthoquinones towards the HT-29 CRC cell line. Furthermore, we have demonstrated the participation of voltage-gated L-type Ca2+ channels in the N4 mechanism.

Keywords: Natural products; Pharmacology; Cytotoxicity; Ion channels; HT-29; Flow cytometry; Calcium imaging

Received: January 14, 2016; Revised: March 9, 2016; Accepted: March 23, 2016; Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Ramos Gonçalves JC, Coulidiati TH, Luís Monteiro A, de Carvalho-Gonçalves LCT, de Oliveira Valença W, de Oliveira RN, et al.. Antitumoral activity of novel 1,4-naphthoquinone derivative involves L-type calcium channel activation in human colorectal cancer cell line. J Appl Biomed. 2016;14(3):229-234. doi: 10.1016/j.jab.2016.03.002.
Download citation

References

  1. Castro, S.L., Batista, D.G., Batista, M.M., Batista, W., Daliry, A., de Souza, E.M., Menna-Barreto, R.F., Oliveira, G.M., Salomão, K., Silva, C.F., Silva, P.B., Soeiro, M.N., 2011. Experimental chemotherapy for changes disease: a morphological, biochemical, and proteomic overview of potential trypanosoma cruzi targets of amidines derivatives and naphthoquinones. Mol. Biol. Int. 2011, 1-13. Go to original source... Go to PubMed...
  2. Clapham, D.E., 2007. Calcium signaling. Cell 131, 1047-1058. Go to original source... Go to PubMed...
  3. Coulidiati, T.H., Dantas, B.B., Faheina-Martins, G.V., Gonçalves, J. C., do Nascimento, W.S., de Oliveira, R.N., Camara, C.A., Oliveira, E.J., Lara, A., Gomes, E.R., Araújo, D.A., 2015. Distinct effects of novel naphthoquinone-based triazoles in human leukaemic cell lines. J. Pharm. Pharmacol. 67 (12), 1682-1995. Go to original source... Go to PubMed...
  4. da Cruz, E.H., Hussene, C.M., Dias, G.G., Diogo, E.B., de Melo, I.M., Rodrigues, B.L., da Silva, M.G., Valença, W.O., Camara, C.A., de Oliveira, R.N., de Paiva, Y.G., Goulart, M.O., Cavalcanti, B. C., Pessoa, C., da Silva Júnior, E.M., 2014. 1,2,3-Triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachones. Bioorg. Med. Chem. 22 (5), 1608-1619. Go to original source... Go to PubMed...
  5. Dar, M.A., Shrivastava, S., Iqbal, P.F., 2015. Click chemistry and anticancer properties of 1,2,3-triazoles. World J. Pharm. Res. 4, 1949-1975. Go to original source...
  6. Giffin, M.J., Heaslet, H., Brik, A., Lin, Y.C., Cauvi, G., Wong, C.H., McRee, D.E., Elder, J.H., Stout, C.D., Torbett, B.E., 2008. A copper(I)-catalyzed 1,2,3-triazole azidealkyne click compound is a potent inhibitor of a multidrug-resistant HIV1 protease variant. J. Med. Chem. 51, 6263-6270. Go to original source... Go to PubMed...
  7. Gonçalves, J.C., Silveira, A.L., de Souza, H.D., Nery, A.A., Prado, V. F., Prado, M.A., Ulrich, H., Araújo, D.A., 2013. The monoterpene (-)-carvone: a novel agonist of TRPV1 channels. Cytom. Part A 83 (2), 212-219. Go to original source... Go to PubMed...
  8. Hussein, N., Lopes, C.C., Pernambuco Filho, P.C., Carneiro, B.R., Caseli, L., 2013. Surface chemistry and spectroscopy studies on 1,4-naphthoquinone in cell membrane models using Langmuir monolayers. J. Colloid. Interface Sci. 402, 300-306. Go to original source... Go to PubMed...
  9. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., 2011. Global cancer statistics. CA Cancer J. Clin. 61, 69-90. Go to original source... Go to PubMed...
  10. Jemal, A., Simard, E.P., Dorell, C., Noone, A.-M., Markowitz, L.E., Kohler, B., Eheman, C., Saraiya, M., Bandi, P., Saslow, D., Cronin, K.A., Watson, M., Schiffman, M., Henley, S.J., Schymura, M.J., Anderson, R.N., Yankey, D., Edwards, B.K., 2013. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J. Natl. Cancer Inst. 105, 175. Go to original source... Go to PubMed...
  11. Kayashima, T., Mori, M., Yoshida, H., 2009. 1,4-Naphthoquinone is a potent inhibitor of human cancer growth and angiogenesis. Cancer Lett. 278, 34-40. Go to original source... Go to PubMed...
  12. Kolb, H.C., Sharpless, K.B., 2009. The growing impact of click chemistry on drug discovery. Drug Discov. Today 8, 1128-1137. Go to original source... Go to PubMed...
  13. Li, M., Xiong, Z.-G., 2011. Ion channels as targets for cancer therapy. Int. J. Physiol. Pathophysiol. Pharmacol. 3, 156-166. Go to PubMed...
  14. Nascimento, W.S., Camara, C.A., Oliveira, R.N., 2011. Synthesis of 2(1H-1,2,3-triazol-1-yl)-1,4-naphthoquinones from 2azido-1,4-naphthoquinone and terminal alkynes. Synthesis 20, 3220-3224. Go to original source...
  15. Padhye, S., Dandawate, P., Yusufi, M., Ahmad, A., Sarkar, F.H., 2012. Perspectives on medicinal properties of plumbagin and its analogs. Med. Res. Rev. 32, 1131-1158. Go to original source... Go to PubMed...
  16. Parkash, J., Asotra, K., 2010. Calcium wave signaling in cancer cells. Life Sci. 87, 587-595. Go to original source... Go to PubMed...
  17. Siegel, R.L., Miller, K.D., Jemal, A., 2015. Cancer statistics, 2015. CA Cancer J. Clin. 65, 5. Go to original source... Go to PubMed...
  18. Simone, R.D., Chini, M.G., Bruno, I., Riccio, R., Mueller, D., Werz, O., Bifulco, G., 2011. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1,5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents. J. Med. Chem. 54, 1565-1575. Go to original source... Go to PubMed...
  19. Wang, X.-T., Nagaba, Y., Cross, H.S., Wrba, F., Lin Zhang, L., Sandra, E., Guggino, S.A., 2000. The mRNA of L-type calcium channel elevated in colon cancer. Am. J. Pathol. 157, 1549-1562. Go to original source... Go to PubMed...
  20. Wang, X.L., Wan, K., Zhou, C.H., 2010. Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities. Eur. J. Med. Chem. 45, 4631-4639. Go to original source... Go to PubMed...
  21. Wellington, K.W., 2015. Understanding cancer and the anticancer activities of naphthoquinones - a review. RSC Adv. 5, 20309-20338. Go to original source...
  22. Zawadzki, A., Liu, Q., Wang, Y., Melander, A., Jeppsson, B., Thorlacius, H., 2008. Verapamil inhibits L-type calcium channel mediated apoptosis in human colon cancer cells. Dis. Colon Rectum 51, 1696-1702. Go to original source... Go to PubMed...
  23. Zhang, L., Zhou, W., Velculescu, V.E., Kern, S.E., Hruban, R.H., Hamilton, S.R., Vogelstein, B., Kinzler, K.W., 1997. Gene expression profiles in normal and cancer cells. Science 276, 1268-1272. Go to original source... Go to PubMed...